HYFT.US MindWalk Holdings Corp.

Healthcare IT Services USA Stocks
0.9900 USD
Close of Nov 15, 2026
0.9111 2.99
Market cap
USD 47.1M
P/E
-
P/B
10.11x
ROE
-357.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.

Is HYFT.US undervalued?

Graham number

The Graham number of MindWalk Holdings Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MindWalk Holdings Corp. fundamental analysis

No fundamental analysis for MindWalk Holdings Corp. yet.

MindWalk Holdings Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MindWalk Holdings Corp.

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company is headquartered in Austin, Texas.

Full company profile